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Abstract 
Tendinopathy is any injury to a tendon. With an injury to the tendon sheath or 
tendon, the injury response phase is activated, which is mediated by growth factors. A 
growth factor is a physiological component of plasma in the blood. These factors bind and 
signal for proteins to regulate cellular processes to aid in the healing of tissue. With this 
understanding of how growth factors in blood platelets aid in the healing process, a 
platelet-rich plasma (PRP) injection has been developed. In a PRP injection, the increase in 
platelet concentration is thought to promote cell proliferation in patients suffering from 
chronic tendon pathologies. After developing a clinical question, I attempt to answer it by 
analyzing four recent studies. 
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Process Analysis 
Over the course of being in the Athletic Training program, I have been exposed to 
many different treatment options for patients suffering from chronic pathologies. During 
my senior fall semester, I had the opportunity to learn from a physiatrist. After talking to 
him about new and upcoming topics in the medical world, he suggested I look into platelet-
rich plasma injections (PRP). The PRP injection uses a person's body to attempt to heal 
their body. I thought that this was a very unique and interesting concept that inspired me 
to write a critically appraised topic focusing on the effects of PRP injections on patients 
with tendinopathy. As many athletes deal with tendinopathy at some point and time during 
their athletic career, I wanted the research to support PRP injections as a treatment 
modality for these people chronically suffering. 
Once my topic was established, the first step to finding information was using the 
library databases as outlined in my thesis to gather the necessary data. Once I found four 
articles related to my clinical question I was able to analyze this to form an opinion and 
conclusion. To share the research and conclusions I found during my research, I have 
written a critically appraised topic for medical colleagues to be able to reference multiple 
opinions in one place. I also created a poster that was presented to my peers and advisors 
during the program end of the year banquet. In addition to this brief presentation, I also 
presented in a formal setting to my peers and advisors. Throughout this experience I have 
learned the value of continuing education as I enter into a professional career as an athletic 
trainer. I will continue to seek new learning opportunities in order to provide the best 
patient centered care as a health care provider. 
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Clinical Scenario 
Tendinopathy is any injury to a tendon that can range from an acute injury such as a 
tear to a chronic tenosynovitis. Specifically, tenosynovitis is a degeneration of the tendon, 
which results in the inflammation of the tendon sheath. With an injury to the tendon sheath 
or to the tendon, the injury response phases are activated. During the first phases of injury 
response, healing commences and is mediated by growth factors. More specifically, growth 
factors bind to cell-surface receptors and initiate an intracellular signal resulting in protein 
formationl. The newly formed proteins regulate cell proliferation, cellular chemical 
movement, new blood cell formation, cell differentiation, and extracellular matrix 
formation; indicative of regeneration and healing1. Platelets in a patient's blood are known 
to contain many of these desirable growth factors1. The healing of tendons occurs through 
a dynamic process in 3 overlapping growth factor regulated phases. In a platelet-rich 
plasma injection, these growth factors are increased in concentration. In vitro, the platelet 
rich plasma (PRP) injection has been shown to promote cell proliferation, indicating the 
ability to halt excess inflammation while activating proliferation and maturation2• In recent 
studies, research suggests that the growth factors in platelet-rich plasma (PRP) will 
expedite the healing process and in turn decrease the perception of pain and improve 
function of an affected joint. 
Focused Clinical Question 
Do platelet-rich plasma injections improve perceived pain and function of adult patients 
with tendinopathy in the body? 
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Summary of Search, "Best Evidence" Appraised, and Key Findings 
• The literature was search for studies of level 3 or higher that investigated the effects of 
PRP injections on pain and function in patients with diagnosed tendinopathy. 
• The literature search identified seven possible studies related to the clinical question; 
three randomized control trials3A,S and 1 cohort study6 met the inclusion criteria set for 
this critically appraised topic. 
• Of the included articles, three studies3A,S examined the effects of platelet-rich plasma 
injections compared to a control. One study6 looked at the effects of one PRP injection in 
patients with tendinopathy over time. All studies included measures of pain as well as 
function through the use of a patient related outcome measure (PROM) each varying 
based on injury location. 
• Overall, three studies3, 4• 5 concluded PRP injections were a not better than placebo 
treatment option for patients with tendinopathy, while one studies6 indicated there was 
statically significant difference in PRP injection versus no treatment. 
Clinical Bottom Line 
There is inconsistent evidence to support the use of PRP injections on perception of 
pain and function in individuals with tendinitis or tendinopathy. Pain did decrease in 
patients however not significantly when compared to a placebo group. Function did not 
improve faster compared with a saline or autologous blood injections. PRP injections did 
show a decrease in pain and an increase in function however; PRP injections did not show 
any difference in improvements from placebo treatments or naturally healing body. 
3 
Strength of Recommendation 
There is a grade "B" evidence to support the use of PRP injection to decrease pain 
and increase function in patients with tendinopathy as determined by the inconsistency of 
studies3-6. 
Search Strategy 
Terms Used to Guide Research Strategy 
• Patient/Client group: patients with tenosynovitis 
• Intervention: platelet-rich plasma injection 
• Comparison: None 
• Outcomes: perceived pain and function 
Sources of Evidence Searched 
• CINAHL 
• PubMed 
• Sports Discus 
• MedLine 
Inclusion and Exclusion Criteria 
Inclusion Criteria 
• English Language 
• Published in last 10 years 
• Level of evidence of 3 or higher 
• Participants age 18 years or older 
• Human beings 
• Patients treated with PRP injection 
• Patients with tendinopathy 
Exclusion Criteria 
• Not available in English 
• Published prior to 2007 
• Case Study, Case Series, or lower than level of evidence of 3 
• Patients without tenosynovitis 
• Patients younger than 18 years of age 
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Results of Search 
Level of Evidence Study Reference 
Design 
2 RCT Creaney et aP, Kesikburun et al
4, 
Krogh et al5 
3 Cohort Sanli et al6 
Table 1: Summary of Study Designs of Articles Retrieved 
Four studies were located and categorized as shown in Table 1 (based on levels of 
evidence, Centre for Evidence Based Medicine, 2011)7. 
Best Evidence 
The following studies (Table 2) were identified as the best evidence and selected for 
inclusion in this critically appraised topic (CAT). Reasons for selecting these studies were 
they were a level of evidence of 3 or higher, included patients diagnosed with 
tendinopathy, and examined the effectiveness of platelet-rich plasma injections as a 
modality to treat pain and improve function. 
Implications for Practice, Education, and Future Research 
A platelet-rich plasma injection contains bioactive elements for musculoskeletal 
tissue healing and has been an interest of orthopedic surgeons for many years. In normal 
blood, the platelet count ranges from 150,000/IJ.L to 350,000/1J.L1. Platelets are cytoplasmic 
fragments of megakaryocytes and play a role in cellular hemostasis 1. Platelets are known to 
release a burst of proteins that contribute to the healing processes commonly referred to as 
growth factors, which create tissue specific responses. By increasing the concentration of 
platelets to one million per microliter, the amount of growth factor present is increased by 
three to five-fold 2• The growth factors bind to the transmembrane receptors in the cell, 
initiate a signal within the cell, and ultimately result in new protein formation, which is 
responsible for cell proliferation, cellular chemotaxis, angiogenesis, cell differentiation, and 
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Creaney et aJ3 Kesikburun et al4 Krogh et al5 
Study Design 
Participants 
Intervention 
Investigated 
Randomized Control Trial 
1SO participants (8S male, 65 female) 
with a mean age of SO years who had 
failed previous conservative therapy 
including physical therapy exercises 
(stretches and eccentric loading) for 
elbow tendinopathy and had symptoms 
for a minimum of 6 months. Exclusion 
criteria included patients who 
previously had corticosteroid, dry-
needling, or a blood injection .. 80 
participants were assigned to the PRP 
injection group, while 70 participants 
were assigned to the blood control 
group. Patients were blinded to which 
group they were randomly assigned. 
87% of the participants were analyzed 
at follow-up date. 
Patients in both groups were injected 
first with 2ml bupivacaine, followed by 
a 2-minute wait. Then patients were 
injected with l.SmL blood (234 
platelets X 109 /injection) or 1.SmL PRP 
(6S2 platelets X 109 /injection) to the 
affected elbow according to grouping. 
Patients were then instructed to 
continue normal activities while 
avoiding physical activity or heavy 
lifting. lee was allowed as well as 
analgesic. Patients were instructed to 
avoid NSA!Ds. The same blinded 
operator using same technique for all 
patients performed injections. All 
patients had two injections at time 0 
and 1 month. 
Randomized Control Trial 
40 patients (18-70 years of age) with a 
history of shoulder pain for longer than 
3 months during overhead activities, 
MRI findings indicating rotator cuff 
tendinopathy (RCT) or partial tendon 
ruptures, and a minimum of SO% 
reduction in shoulder pain with 
subacromial injections of an anesthetic. 
Patients were randomly and blindly 
assigned to a PRP group (n=20) and a 
placebo group ( n=20). Exclusion criteria 
included a full thickness tear, presence 
of another disease that may cause 
shoulder pain, a systemic disease, a 
hemoglobin level lower than 11g/dL, 
pregnancy, or a history of subacromial 
or intra-articular steroid injection. 
97.S% of the participants were 
available for final follow-up assessment. 
All participants, clinician and evaluator 
remain blinded throughout the study. In 
all participants, injections were made 
under the posterolateral aspect of the 
acromion using real-time ultrasound 
guidance. First a 1% lidocaine injection 
was administered followed by the 
designated solution, SmL PRP with a 
four fold increase in platelets or SmL 
saline solution. After the injection, 
patients remained lying supine without 
moving the shoulder for 1S minutes. All 
patients then underwent a standard 
rehabilitation protocol for a total of 6 
weeks and were told to rest from all 
overhead activity in the first 2 days. 
Table 2: Characteristics of Included Studies 6 
Randomized Control Trial 
24 patients with Achilles 
tendinopathy (AT) were included. 
The patients must have had AT 
symptoms for more than 6 months, a 
clinical diagnosis with pain and 
thickened tendon, and an ultrasound 
diagnosis of thickened tendon and 
visual signs oftendinopathy. 
Exclusion criteria included patients 
younger than 18 years of age, 
glucocorticoid injection, previous AT 
surgery, or any known inflammatory 
disease. The groups were randomly 
allocated, 12 in each group. There 
was no dropout at the 3 month time 
period. However 16 patients dropped 
out prior to the 12-month 
assessment due to unsatisfactory 
effects. Six patients remained in the 
placebo group, while two remained 
in the PRP group for the 12-month 
follow up exam. 33% of the 
participants were available for the 
final follow-up assessment. 
All patients underwent an 
ultrasound-guided injection 
technique. PRP and saline were 
injected into 7 tendon perforations in 
the thickest part of the tendon. 6mL 
of saline was injected for the control 
group. In the PRP injection, 6mL of 
PRP with a platelet concentration 
increased on average by 8 fold 
compared with whole blood. Patients 
were advised to minimize strain on 
AT and gradually increase 
rehabilitation below pain limit. The 
rehabilitation was an at-home 
standard protocol, however the 
length of this protocol was not stated. 
This study was single blinded. 
Sanli et al6 
Cohort 
12 participants (10 male, 2 female) 
were included in this study. The median 
age was 41 years. The participants were 
eligible if they were 18 years or older, 
unresponsive to physical therapy, non-
steroidal anti-inflammatory, or steroid 
injections, and had a diagnosis of distal 
biceps tendonitis. Exclusion criteria 
were pregnancy, systemic diseases, 
previous surgery for elbow tendinitis, 
neurological disorders, uncooperative 
patients, steroid injection within 3 
months or complete tendon rupture. 
100% were present for follow up. 
All patients had an ultrasound-guided 
injection performed in a supine position 
by two clinicians. The injection of three 
microliters ofL-PRP and sodium 
bicarbonate buffer was administered to 
the distal end of the biceps tendon. Post 
treatment regime included eccentric 
exercises to biceps and tendon. 
Creaney et all Kesikburun et al4 Krogh et als 
Outcome 
Measures 
Main Findings 
Level of 
Evidence 
Validity Score 
Conclusion 
Patient-Related tennis elbow evaluation 
{PRTEE) score was used to measure 
pain and physical function. The range of 
scores for the PRTEE is 0-100. PRTEE 
was completed at baseline, 1 month, 3 
months, and 6 months. The same 
assistant administered the 
questionnaire each time. 
Over the course of 6 months, PRTEE 
scores decreased in both groups, 
indicative of decreased pain in both PRP 
injection patients as well as blood 
injection patients. 25 points on the scale 
showed clinically significant 
improvement. The mean score was a 49 
at the beginning of the study. At 
baseline the PRTEE1 the mean was 45.8 
for plasma and 52.5 in the blood group, 
indicating both groups are comparable. 
The mean score of PRTEE was 35.8 
{95% Cl 30.3 to 41.4) in the PRP 
injection group, where the mean PRTEE 
score was 46.8 (95% Cl42.1 to 51.5) in 
the blood injection group using a X2 test. 
Both improvements were greater than 
the predetermined clinically significant 
improvement of 25. No statistical p 
values were reported. 
1 
PEDro 10/10 
PRP and blood injections are important 
as a secondary option for patients with 
elbow tendinopathy in which 
conservative treatment has failed. The 
primary treatment of elbow 
tendinopathy should remain 
conservative treatment. 
The primary outcome measure was the 
Western Ontario Rotator Cuff (WORC) 
Index, which assesses the quality of life 
for patients suffering from rotator cuff 
disease. The score possible ranged from 
0-2100, the higher score indicating 
worse functioning. The secondary 
outcome measures were the Shoulder 
Pain and Disability Index (SPADI) 
scores represented as a percentage 0-
100%, the Neer impingement sign 
(using VAS score for pain 0-1 0), and a 
passive range of motion test using a 
goniometry. Outcome measures were 
assessed at baseline, 3 weeks, 6 weeks, 
12 weeks, 24 weeks, and 1 year after 
the injection by a blinded researcher. 
In both treatment groups, significant 
improvement was seen in the WORC 
score at all assessment points (P<.001). 
The SPADI and VAS (Neer impingement 
sign) scores also showed similar 
improvement in both groups (P<.001). 
There was no statistical difference in 
the amount of improvement in scores 
between groups for any outcome 
measure at any time point (P>.063-
.947). 
1 
PEDro 10/10 
PRP injections were found to be no 
more effective in improving quality of 
life, pain, disability, and shoulder range 
of motion than the placebo in patients 
with chronic rotator cuff disease within 
a 1-year study. PRP injections are not 
supported. 
Table 2: Characteristics of Included Studies 
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The primary outcome measure was 
the VISA-A after 3 months. The VISA-
A is a Danish patient related outcome 
measure. The secondary outcome 
measures were changes in pain at 
rest, when walking, and when AT was 
squeezed. The VISA-A scores range 
from 0 to 100, 100 indicating optimal 
function. The pain scale used was 0, 
no pain, to 10, worst pain imaginable. 
The 3-month data was chosen as the 
primary data due to the extensive 
dropout rate. 
There was no statistically significant 
difference between PRP and saline 
injections in the VISA-A (95% Cl, 
P=.868). In the secondary outcome 
measures there were no statistically 
significant difference between 
groups. Pain at rest, P=.137, pain 
when walking P=.544, and pain when 
AT squeezed P= .208. Tendon 
thickness was the only place where 
there was a statically significant 
difference, P=.030, indicating an 
increase in tendon thickness after 
PRP injection. 
1 
PEDro 6/10 
1 injection of PRP when compared 
with one injection of saline did not 
resu lt in significant improvement in 
perceived quality of life or decrease 
pain with Achilles tendinopathy. 
Sanli et al6 
The primary outcome measure was a 
Visual Analogue Scale (VAS) rest and 
activity pain scores on a scale of0-10. 
The secondary outcome measure was 
the elbow functional assessment (EFA) 
score. The range of scores possible was 
0-100. Outcome measures were 
assessed at baseline as well as at an 
average of 47 months post injection. 
All patients showed significant 
improvement in pain and function. The 
VAS pre-intervention score at rest was 6 
and post intervention was 0.5 with 
p<.002. The VAS pre-intervention score 
during activity was 8 and post 
intervention was 2.5 with p<.002. The 
EFA pre-intervention score was 63 and 
post intervention score was 90 with 
p<.004. All patients were satisfied with 
outcomes at final follow-up. 
3 
STROBE 19/22 
All patients showed a significant 
improvement in VAS rest and activity 
scores and improvement in EFA scores. 
US-guided PRP injections were an 
effective treatment for symptomatic 
distal biceps tendinopathy. 
extracellular matrix production1. The PRP injection is thought to increase the 
concentration of growth factors and will cause an increase in the recovery process2• 
The four studies3-6 included in this CAT examined the relationship between platelet-
rich plasma injections and perceived pain and function in individuals suffering from 
tendinopathy. The studies3-s divided individuals with tendinopathy into two groups that 
were associated with a PRP injection and a blood control group3 and a PRP injection group 
and a saline control group4-s. The final study was a cohort study with PRP injection group6. 
Three of the studies3-s revealed there was no benefit of PRP injections versus an autologous 
blood injection or saline injection. Sanli et al6 concluded there was a decrease in pain and 
an increase in function of a person with distal biceps tendinitis following PRP injection. 
Because there was no control or comparison, it is difficult to know how effective the 
treatment was on patients. 
To create these PRP injections, the blood is typically collected through the 
antecubital vein. A centrifuge is then used to separate the platelets from the plasma. All 
studies included in this paper used different techniques to isolate the platelets. Because the 
platelets are collected from the individual patient, the concentration of platelets also varies. 
The differences in the PRP injections could have been a cause of the varying results from 
studies3-6, However, this variance in the injections is a naturally occurring error in the 
procedure and could not have been avoided in any of the studies. 
The current applications of PRP injections indicate patients with tendonitis would 
benefit due to the increase in concentration of growth factors. However, this was not 
demonstrated in three out of the four studies. Wroblewski et aF stated PRP injections may 
halt the excess inflammation, which would inhibit the fibrous scar tissue that goes along 
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with the healing of tendon to bone. While the PRP injection does activate proliferation and 
maturation, the decreased inflammation associated with the altered healing process could 
suggest why three studies3·5 showed no significant improvement compared to the control 
groups. The variation in the techniques of obtaining the platelet-rich plasma could have 
accounted for why no results were seen when compared to the control groups. Because 
different techniques were used a variation of concentrations of platelets was seen in all of 
the studies3-s with no report of concentration in the Sanli6 study. 
In addition to the differences in PRP injection, a variation in results could have been 
due to the focus solely on patient reported outcome measures. These measures take into 
account the minimal difference that is important to the patient, however this type of data 
can subjective person to person. Because of the strict focus on patient reported 
information, it makes it difficult to conclude that the PRP injection wasn't helping but 
instead to say that the thought of an injection in general was creating the necessary results 
for the patient to think they are benefitting. However typically when looking at medical 
related data, patient report data is of the highest value because of the focus on patient 
centered care. The outcome measures could be seen as a strength of the studies3-6 or also as 
a deficit that could be overcome by objective data collection. 
The study5 by Krogh and his colleges was difficult to use because of the large 
number of dropouts that were reported. The large mortality rate caused the researchers to 
shift their data collection to the three-month post-injection exam rather than the twelve-
month post-injection exam. No other study reported this high of a drop out rate. The 
participants in this study were allowed to drop out if they felt they were not achieving the 
results desirable and were able to switch to a different treatment plan. With this flexibility 
9 
in study design, it allowed a high percentage of drop out early in the study, which forced a 
change in data analysis. The subjects in this study were not obtaining the results they 
desired attributing to the conclusion of this study. The results of the study5 did not support 
the use of PRP injections in the treatment of tendinopathy, similar to two of the other 
studies3.4. 
Biochemically, the PRP injection should help to decrease the symptoms of 
tendinopathy. However, it was not clinically proven to decrease pain or increase function 
any quicker than the normal healing process. More research in the future needs to be 
collected in a more athletic and younger population to be able to justify the use of the PRP 
injection with athletes for the treatment of tendinopathy or tendinitis. Because there were 
no adverse reactions to the PRP injection, it is a safe treatment option to try, which lends 
itself well to further research. In addition to a more specific patient population, the PRP 
injection could be looked at to treat an acute injury. By adding additional growth factors, it 
could add an additional kick-start to the healing process in the initial injury response 
process. More research needs to be completed to to definitively determine if there is a 
benefit to treating a patient suffering from tendinopathy with PRP injections. 
For research in the future, a more standardized creation of the PRP injection needs 
to be used. To increase specificity, studies need to focus on one location in the body. These 
studies3·6 looked at very different anatomical joints within the human body. While the main 
outcome measures examined in this critically appraised topic were patient related, imaging 
could be done to identify if there are physiological advantages of administering these 
injections to patients. 
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While the PRP injection is thought to alleviate symptoms of tendonitis, it is 
challenging to conclude that they have significant influence. All four of the studies looked at 
tendonitis in different regions of the body. The lack of consistency of the injection along 
with the lack of consistency in the tendon treated causes difficulty in synthesizing the 
results of this compilation to support the use of PRP injections for afflicted tendon tissues. 
In conclusion, four studies3-6 investigated the effectiveness of PRP injections on 
perception of pain and function in individuals with tendinitis or tendinopathy and found 
the PRP injections to decrease pain and increase function but there were no significant 
results when compared to a placebo group. Future research is needed to examine the 
physiological events occurring after the treatment ofPRP injection to identify if the 
injection results in any advantage for healing of the afflicted tendon tissue. This critically 
appraised topic should be reviewed in two years to determine whether there is additional 
evidence that could change the clinical bottom line. 
11 
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Introduction 
Clinical Scenario: Tendinopathy is any injury to a tendon. With 
an injury to the tendon sheath or to the tendon, the injury 
response phases are activated. During the first phases of injury 
response, healing commences and is mediated by growth 
factors. Growth factors bind to cell·surface receptors and initiate 
an intracellular signal resulting in protein formation. The neYJiy 
formed proteins regulate cell proliferation, cellular chemical 
movement, new blood cell formation, cell differentiation, and 
extracellular matrix formation; indicative of regeneration and 
healing. Platelets in a patient's blood are known to contain 
many of these desirable growth factors1·1n a plasma-rich 
platelet injection, these growth factors are increased in 
concentration. In vitro, the plasma rich platelet (PRP) injection 
has been shown to promote cell proliferation, indicating the 
ability to halt excess inflammation 'vVhile activating proliferation 
and maturation2. 
Focused Clinical Question: Do plasma rich platelet injections 
improve perceived pain and function of patients with 
tendinopathy in the body? 
Summary of Search, '18est Evidence" appraised and Key 
Findings; The literature was search for studies of level 3 or 
higher that investigated the effects of PRP injections on pain 
and function in patients with diagnosed tendinopathy. Of the 
included articles, three studies3·4·5 examined the effects or 
platelet-rich plasma injections compared to a control. One 
study6 looked at the effects of one PRP injection in patients Ylith 
tendinopathy over time. All studies included measures of pain 
as well as function. 
Methods 
Search Strategy 
• Patient/Client group; patients with tenosynovitis 
• Intervention: platelet-rich plasma injection 
• Comparison: None 
• Outcomes: perceived pain and function 
Sources of Evidence Searched 
• CINAHL 
• PubMed 
• Sports Discus 
• MedUne 
Inclusion and Exclusion Criteria 
Inclusion 
• English Language 
• Published in last 10 years 
• Human beings 
• Patients treated with PRP 
injection 
• Patients with tenosynovitis 
Exclusion 
• Case Study, Case Series, or 
lower than level of evidence 
of 2 
• Patients without 
tenosynovitis 
• Patients younger than 18 
years of age 
Results of Searc h: Four studies were located and categorized 
as shown in Table 1 (based on levels of evidence. Centre for 
Evidence Based Medicine, 201 1). 
Study Design 
RCT 
Cohort 
Reference 
Creaney et aP, 
Kesikburun et at4, 
Krogh et al5 
Santi et ale 
Table 1. Summary of Study Designs of Articles Retrieved. 
Hannah Johnson 
Ball State University, Muncie IN 
Creaney et al3 Kesikburun et al' Krogh et al5 Sanli et al1 
Study Design Randomized Control Trial Randomized Control Trial Randomized Control Trial Cohort 
Participants 
Intervention 
Investigated 
Outcome 
Measures 
Main Findings 
l evel of 
Evidence 
150 participants who had failed 40 patients with a history of 
conservative exercises for shoulder pain for longer than 3 
elbow tendinopathy and had months during overhead 
symptoms for a minimum of 6 activities. 97.5% of the 
months. 87% of the participants participants were available for 
were analyzed at follow-up date. final follow-up assessment. 
24 paUents with Achilles 12 participants were included in 
tendinopathy (An were this study. Had a diagnosis of 
included. The patients must distal biceps tendonitis. 100% 
have had AT symptoms for more were present for follow up. 
than 6 months. 
Patients in both groups were In aU participants, injections All patients underwent an All patients had an ultrasound-
injected first with 2ml were made under the ultrasound-guided injection guided injection performed in a 
bupivacaine, followed by a 2· posterolateral aspect of the technique. PRP and saline were supine position. The injection of 
minute wait. Then patients were acromion using real-time injected into 7 tendon three microliters of L-PRP and 
injected with 1.5ml blood (234 ultrasound guidance. First a 1% perforations in the thickest part sodium bicarbonate buffer was 
platelets X 109/injection) or lidocaine injection was of the tendon. 6ml of saline was administered to the distal end of 
1.5mlPRP (652 platelets X 109/ administered followed by the injected for the control group. In the biceps tendon. 
injection) to the affected elbow designated solution, 5ml PRP the PRP injection, 6ml of PRP 
according to grouping. All 'Nith a four fold increase in with a platelet concentration 
patients had !'NO injections at platelets or 5ml saline solution. increased on average by 8 fold 
time 0 and 1 month. compared with 'vVhole blood. 
Patient-Related tennis elbow The primary outcome measure The primary outcome measure The primary outcome measure 
evaluation (PRTEE) score was was the We stem Ontario Rotatorwas the VISA-A after 3 months. was a VAS rest and activity pain 
used to measure pain and Cuff (WORC) Index. The The secondary outcome scores. The secondary outcome 
physical function. PRTEE was secondary outcome measures measures were changes in pain measure was the EFA score. 
completed at baseline, 1 month, were SPADI, the Neer at rest, when walking, and 'vVhen Outcome measures were 
3 months, and 6 months. impingement sign, and a passiveAT was squeezed. The 3-month assessed at baseline as well as 
range of motion test. All were data was chosen as the primary at an average of 4 7 months post 
assessed at baseline, 3 weeks, data due to the extensive injection. 
6 weeks, 12 weeks, 24 weeks, dropout rate. 
and 1 year after the injection. 
Over the course of 6 months, In both treatment groups, 
PRTEE scores decreased in significant improvement was 
both groups, indicative of seen in the WORC score at all 
decreased pain in both PRP assessment points (P<.001). 
injection patients as well as The SPADI and Neer 
blood injection patients. The impingement sign scores also 
mean score of PRTEE was 35.8 showed similar improvement in 
(95% Cl30.3 to 4tA) in the PRPboth groups (P<.001). There 
injection group, INhere the mean was no statistical difference in 
PRTEE score was 46.8 (95% Cl the amount of improvement in 
42.1 to 51 .5) in the blood scores between groups for any 
injection group using a X2 test. outcome measure at any time 
No statistical p values were point {P>.063-.947). 
reported. 
There was no statistically All patients showed significant 
significant d ifference between improvement in pain and 
PRP and saline injections in the function. The VAS pre-
VISA·A (95% Cl, P=.868). In the intervention score at rest was 6 
secondary outcome measures and post intervention was 0.5 
there were no staUstically 'Nith p<.002. The VAS pre-
significant difference between intervention score during activity 
groups. Pain at rest, P=.137, was 8 and post intervention was 
pain when walking P=.544, and 2.5 with p<.002. The EFA pre· 
pain 'vVhen AT squeezed P= . intervention score was 63 and 
208. Tendon thickness was the post intervention score was 90 
only place where there was a 'Nith p<.004. 
statically significant difference, 
P=.030. 
Validity Score PEDro 10/10 PEDro 10/10 PEDro 6/10 STROBE 19/22 
Conclusion PRP and blood injections are PRP injections were found to be 1 injection of PRP when All patients showed a significant 
important as a secondary option no more effective in improving compared 'Nith one injection of improvement in VAS rest and 
for patients with elbow quality of life, pain, disability, and saline did not result in significant activity scores and improvement 
tendinopathy in 'vVhich shoulder range of motion than improvement in perceived in EFA scores. US-guided PRP 
conservative treatment has the placebo in patients with quality of life or decrease pain injections were an effective 
failed. The primary treatment of chronic rotator cuff disease with Achilles tendinopathy. treatment for symptomatic distal 
elbow tendinopathy should within a 1-year study. PRP biceps tendinopathy. 
remain conservative treatment. injections are not supported. 
Table 2. Characteristics of Included Studies 
Clinical Bottom Line 
There is inconsistent evidence to support the use of PRP injections on perception of pain and function in individuals with tendinitis or tendinopathy. Pain 
was not decreased due to the injection of PRP. Function did not improve faster than when compared with a saline or autologous blood injection. 
Strength of Recommendation: There is a grade 8 evidence to support the use of PRP injection to decrease pain and increase function in patients with 
tendinopathy. It is a grade 8 of evidence because the findings of the studies:s-s are inconsistent and do not support the use of PRP injections. 
-u N V E R S l T Y. 
Implications for Practice, 
Education, and Future 
Research 
The four studies)-6 included in this CAT examined the 
relationship between platelet-rich plasma injections and 
perceived pain and function in individuals suffering from 
tendinopathy. 
Three of the studiesl-5 revealed there was no benefit of PRP 
injections versus an autologous blood injection or saline 
injection. Santi et al6 concluded there was a decrease in pain 
and an increase in function of a person with distal biceps 
tendinitis following PRP injection. 
Wroblewski et al2 stated PRP injections may halt the excess 
inflammation, 'vVhich would inhibit the fibrous scar tissue that 
goes along wHh the healing of tendon to bone. The decreased 
inflammation associated with the altered healing process 
could suggest INhy three studies:s-5 showed no significant 
improvement compared to the control groups. 
All studies)-6 used a outcome measures to assess patient 
related outcomes 'vVhich include assessing pain and function 
through various measures. Most commonly used was the 
visual analog pain scale as well as different patient related 
outcome measures (PROM). 
A variation of concentrations of platelets was seen in all of 
the studies:s..s with no report of concentration in the Sanli6 
study. 
PRP injections were not clinically proven to decrease pain or 
increase function any quicker than the normal healing 
process. 
More research in the future needs to be collected in a more 
athletic and younger population to be able to justify the use of 
the PRP injection in athletes for the treatment of tendinopathy 
or tendinitis. The populations used in the studiesl-6 were small 
and d id not encompass an active group of people. 
The four studiesu investigated the effectiveness of PRP 
injections on percepUon of pain and function in individuals 
with tendinitis or tendinopathy and found the PRP injection to 
be ineffective overall. 
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PLATELET-RICH PLASMA INJECTION 
EFFICACY IN TENDINOPATHY IN ADULT 
PATIENTS 
A Critically Appraised Topic 
Hannah Johnson 
CLINICAL SCENARIO 
PROCESS OF PRP THERAPY 
1 
,__,..A--y+-·--
Collect blood 
30-60ml of blood is drawn from 
the patient's arm. 
www.stemcellorthopedic.com 
Figure 2: Process of PRP Therapy4• 
2 
Separate the platelets 
The blood is then placed in a 
centrifuge. The centrifuge spin.s 
and separates ·the platelets 
from t!he rest of the blood 
components. 
3 
·-· - PLAnUT· PQOR PLASIAA 
~--- PLATllrTAKHPUSIAA 
'---- Am IILOOO CRLS 
Extract platelet-rich plasma 
Extract 3-6ml. of platelet-rich 
plasma. 
• • a .fRMQ llif.INSlTTt.JT'[ Of ar.c.a:rAATM: 
-v _ -~MOlLW~~ 
4 
~ '-,,~ 
lnje<:t injured area with PRP 
Using the concentrated 
platelets, we increase the growth 
factors up t.o e ight t imes, which 
promotes temporary relief and 
stops inflammation. 
BACKGROUND-PLATELETS 
• Growth Factors1 
• Activation of growth factors leads to protein 
formation2 
• Proteins regulate 1: 
• Cell proliferation 
• Cellular chemical movement 
• New blood cell formation 
• Cell differentiation 
• Extracellular matrix formation 
• Tendinitis, tennis elbow, rotator cuff repair, 
achilles tendon repair, muscle injuries, bone 
injuries, and ACL repair1 
• Growth factors increase linearly as platelet 
concentration increases 1 
Platelet rich plasma treatment areas 
~,. Llgamen~ sp~in: ~. 
• Triangular Flbrocanilage i 
CQmp~x i 
l 
I 
• Patallat tondonlbs 
• MeM<:uo I 
I • L\)arn<ri(MCL.LCl,ACt,PCl..) 
' • C..r1il!l9&defeds 
Ankle & Foot 
• Plantar Fasciitio ] 
• Ac:hilloJl!tendonO!is • 
• Ankle sprains I 
/S·- ..Ii'J.., __ .... - - _... 
Figure 1: PRP treatment areas3. 
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SEARCH STRATEGY/KEYWORDS 
• Patient/Client group: patients with tenosynovitis 
• Intervention: platelet-rich plasma injection 
• Comparison: None 
• Outcomes: perceived pain and function 
INCLUSION CRITERIA 
• English Language 
• Published in last 10 years 
• Randomized Control Trial, Cohort 
Studies 
• Participants age 18 years or older 
• Human beings 
• Patients treated with PRP injection 
• Patients with tendinopathy 
EXCLUSION CRITERIA 
• Not available in English 
• Published prior to 2007 
• Case Study, Case Series, or lower 
than level of evidence of 2 
• Patients without tenosynovitis 
• Patients younger than 18 years of 
age 
RESULTS OF SEARCH 
Level of Evidence Study Design 
2 RCT 
3 Cohort 
Table 1: Summary of Study Designs of Articles Retrieved. 
Reference 
Creaney et aP, Kesikburun 
et al4, Krogh et al5 
Sanli et al6 
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CREANEY ET Als 
• Study Design: Double blind RCT 
• Participants: 150 participants, 87% were analyzed for at follow up date. 
• Intervention Investigated: PRP injection vs. autologous blood injection. 
• One at initial date, second at 1 month 
• 652 platelets x1 0 I injection 
• Outcome Measure: Patient-related tennis elbow evaluation (PRTEE) 
• Main Findings: Both groups scores decreased. 
• No significant difference 
• Level of Evidence: 1 
• Pedro 10/10 
• Conclusion: PRP was not more effective in treating elbow tendinopathy than autologous 
blood. 
• 
• 
KESIKBURUN ET AL6 
Study Design: Double blind RCT 
Participants: 40 participants with rotator cuff tendinopathy, 
97.5% were analyzed for at follow up date. 
• Intervention Investigated: PRP injection vs. saline injection. 
• Platelet concentration was increased by four fold 
• Outcome Measure: Western Ontario Rotator Cuff (WORC), 
Shoulder Pain and Disability lndex(SPADI), VAS with Neer 
Impingement test, and passive range of motion 
measurement 
• Main Findings: Both groups scores improved. 
• No significant difference between groups 
• Level of Evidence: 1 
• Pedro 10/10 
• Conclusion: PRP was not more effective in treating rotator 
cuff tendinopathy than saline injection. 
"\ -
\..'' 
Rotator cuff problems 
PRP is injected in and around 
the inflamed/torn tendons 
Figure 3: Rotator cuff PRP injection location7· 
KROGH ET Ala 
• Study Design: Single blind RCT 
• Participants: 24 participants, 33% were analyzed 
at final follow up date. 
• Intervention Investigated: PRP injection vs. saline 
injection. 
• Platelet concentration increase by eight fold 
• Outcome Measure: VISA-A (Danish patient related 
outcome measure), Pain Scale 
• Main Findings:. No significant difference between 
groups 
• Tendon thickness increased after PRP 
injection 
• Level of Evidence: 1 
• Pedro 6/10 
• Conclusion: PRP was not more effective in treating 
Achilles tendinopathy than saline injection. 
Figure 4: Ultrasound guided Achilles PRP injection9. 
SANLI ET AL 10 
• Study Design: Cohort 
• Participants: 12 participants with distal biceps tendinitis, 100% were analyzed at final 
follow up date. 
• Intervention Investigated: PRP injection 
• Platelet concentration was not reported 
• Outcome Measure: Visual Analogue Scale (VAS), Elbow Functional Assessment (EFA) 
• Main Findings: All patients showed significant improvement. 
• Level of Evidence: 3 
• STROBE 19/22 
• Conclusion: PRP was effective in treating distal biceps tendinopathy. 
KEY FINDINGS 
• All studies were level 3 of higher 
• 4 studies were included 
• 3 studies looked at the effects of PRP injections versus a control 
• 1 study looked at effects of PRP injections over time 
• 3 studies indicated no significant differences 
• 1 study indicated significant improvement 
CLINICAL BOTTOM LINE 
• Inconsistent evidence 
• PRP injections do not effectively treat pain and function in tendinopathy patients 
• Pain and function did not improve when compared to saline or autologous blood. 
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IMPLICATIONS FOR FURTHER PRACTICE 
• Normal platelet range from 150,000/~L to 350,000/~L 1 
• Platelets to 1 million per microliter, the amount of growth factor present is increased by 3 to 5-
fold2 
• 3 studies used control, 1 study looked at patient reported outcomes 
• Reasons for variation 
• Differences in platelet concentration 
• Naturally occurring differences 
• Different techniques used to obtain injection 
• Halt excess inflammation, while activating proliferation and maturation 
• Large drop outs in Krogh8 
• Future research 
• Population 
• Injury 
• Physiological response 
CONCLUSION 
Four studies5, 6, a, 10 investigated the effectiveness of PRP 
injections on perception of pain and function in individuals with 
tendinitis or tendinopathy and found the PRP injection to be 
ineffective overall. 
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